Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

BHANSALI ENG vs TATVA CHINTAN PHARMA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    BHANSALI ENG TATVA CHINTAN PHARMA BHANSALI ENG/
TATVA CHINTAN PHARMA
 
P/E (TTM) x 16.6 76.6 21.6% View Chart
P/BV x 2.4 5.6 42.2% View Chart
Dividend Yield % 16.8 0.2 10,333.9%  

Financials

 BHANSALI ENG   TATVA CHINTAN PHARMA
EQUITY SHARE DATA
    BHANSALI ENG
Mar-23
TATVA CHINTAN PHARMA
Mar-23
BHANSALI ENG/
TATVA CHINTAN PHARMA
5-Yr Chart
Click to enlarge
High Rs1452,649 5.5%   
Low Rs871,606 5.4%   
Sales per share (Unadj.) Rs67.3191.1 35.2%  
Earnings per share (Unadj.) Rs8.220.5 40.2%  
Cash flow per share (Unadj.) Rs8.824.8 35.6%  
Dividends per share (Unadj.) Rs17.002.00 850.0%  
Avg Dividend yield %14.70.1 15,603.3%  
Book value per share (Unadj.) Rs64.4232.2 27.7%  
Shares outstanding (eoy) m165.9122.17 748.4%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x1.711.1 15.5%   
Avg P/E ratio x14.1103.7 13.6%  
P/CF ratio (eoy) x13.185.7 15.3%  
Price / Book Value ratio x1.89.2 19.7%  
Dividend payout %206.29.7 2,116.1%   
Avg Mkt Cap Rs m19,22847,157 40.8%   
No. of employees `000NANA-   
Total wages/salary Rs m468386 121.2%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m11,1734,236 263.8%  
Other income Rs m28957 503.4%   
Total revenues Rs m11,4624,294 267.0%   
Gross profit Rs m1,778572 310.9%  
Depreciation Rs m9996 103.8%   
Interest Rs m1286 13.6%   
Profit before tax Rs m1,956448 436.9%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m589-7 -8,314.1%   
Profit after tax Rs m1,368455 300.7%  
Gross profit margin %15.913.5 117.9%  
Effective tax rate %30.1-1.6 -1,903.1%   
Net profit margin %12.210.7 114.0%  
BALANCE SHEET DATA
Current assets Rs m8,6673,136 276.4%   
Current liabilities Rs m7972,361 33.7%   
Net working cap to sales %70.418.3 385.4%  
Current ratio x10.91.3 819.1%  
Inventory Days Days523 1,789.9%  
Debtors Days Days77773 1,068.9%  
Net fixed assets Rs m3,0044,304 69.8%   
Share capital Rs m166222 74.9%   
"Free" reserves Rs m10,5144,926 213.4%   
Net worth Rs m10,6805,148 207.5%   
Long term debt Rs m042 0.0%   
Total assets Rs m11,6717,439 156.9%  
Interest coverage x167.96.2 2,705.3%   
Debt to equity ratio x00 0.0%  
Sales to assets ratio x1.00.6 168.1%   
Return on assets %11.87.3 162.6%  
Return on equity %12.88.8 144.9%  
Return on capital %18.410.3 179.2%  
Exports to sales %0.176.2 0.2%   
Imports to sales %056.9 0.0%   
Exports (fob) Rs m143,229 0.4%   
Imports (cif) Rs mNA2,409 0.0%   
Fx inflow Rs m143,229 0.4%   
Fx outflow Rs m7,4592,409 309.6%   
Net fx Rs m-7,445820 -908.3%   
CASH FLOW
From Operations Rs m1,401278 504.3%  
From Investments Rs m-153-1,011 15.1%  
From Financial Activity Rs m-498378 -131.7%  
Net Cashflow Rs m750-357 -210.4%  

Share Holding

Indian Promoters % 57.5 72.0 79.8%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 1.2 16.5 7.2%  
FIIs % 1.1 3.7 30.7%  
ADR/GDR % 0.0 0.0 -  
Free float % 42.5 28.0 152.0%  
Shareholders   122,680 73,730 166.4%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare BHANSALI ENG With:   PIDILITE INDUSTRIES    SRF    BALAJI AMINES    YASHO INDUSTRIES    GHCL    


More on BHANSALI ENG vs TATVA CHINTAN PHARMA

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

BHANSALI ENG vs TATVA CHINTAN PHARMA Share Price Performance

Period BHANSALI ENG TATVA CHINTAN PHARMA S&P BSE OIL & GAS
1-Day 1.33% -0.46% 0.70%
1-Month 16.20% 6.81% 5.96%
1-Year 46.54% -24.74% 59.36%
3-Year CAGR -2.54% -18.87% 24.63%
5-Year CAGR 12.69% -11.79% 13.90%

* Compound Annual Growth Rate

Here are more details on the BHANSALI ENG share price and the TATVA CHINTAN PHARMA share price.

Moving on to shareholding structures...

The promoters of BHANSALI ENG hold a 57.5% stake in the company. In case of TATVA CHINTAN PHARMA the stake stands at 72.0%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of BHANSALI ENG and the shareholding pattern of TATVA CHINTAN PHARMA.

Finally, a word on dividends...

In the most recent financial year, BHANSALI ENG paid a dividend of Rs 17.0 per share. This amounted to a Dividend Payout ratio of 206.2%.

TATVA CHINTAN PHARMA paid Rs 2.0, and its dividend payout ratio stood at 9.7%.

You may visit here to review the dividend history of BHANSALI ENG, and the dividend history of TATVA CHINTAN PHARMA.



Today's Market

Sensex Today Ends 456 Points Lower | IT Stocks Drag | 5 Reasons Why Indian Share Market is Falling Sensex Today Ends 456 Points Lower | IT Stocks Drag | 5 Reasons Why Indian Share Market is Falling(Closing)

After opening the negative note, Indian share markets Slipped further as the session progressed and ended the day weak.